Journal article

Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma

Emma K Baker, Scott Taylor, Ankita Gupte, Alistair M Chalk, Shreya Bhattacharya, Alanna C Green, T John Martin, Dario Strbenac, Mark D Robinson, Louise E Purton, Carl R Walkley

Bone | ELSEVIER SCIENCE INC | Published : 2015

Grants

Awarded by Cancer Council of Victoria


Awarded by NHMRC Career Development Award


Awarded by NHMRC


Awarded by NHMRC Senior Research Fellowship


Funding Acknowledgements

This work was supported by grants from the Cancer Council of Victoria (to C.W., E.B., M.R.; Grant-In-Aid 1047593); NHMRC Career Development Award (to C.W.; 559016); Cure Cancer Australia Foundation Fellowship (to E.B); 5point foundation (to E.B); NHMRC project grant (to L.P.; 1006485); NHMRC Senior Research Fellowship (to L.P.; 1003339); in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute). C.W. is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation. We thank the SVI Flow Cytometry Core Facility (M Thomson, E Orlowski) for FACS sorting and advice.